| |
| |
|
| Insider
Information: |
Andriole Michael T. |
| Relationship: |
|
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
447,021 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$402,274 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
447,021 |
|
|
| Total
Value |
$402,274 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 47.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
Chief Financial Officer |
2018-12-21 |
0 |
2017-02-20 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
|
2024-02-14 |
447,021 |
2019-11-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMRX |
Chimerix Inc |
PRESIDENT AND CEO |
• • – |
2024-02-14 |
4 |
AS |
$1.04 |
$1,809 |
D/D |
(1,744) |
447,021 |
0 |
% |
|
| CMRX |
Chimerix Inc |
PRESIDENT AND CEO |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
83,750 |
448,765 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2023-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,000 |
365,015 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2023-08-01 |
4 |
A |
$1.19 |
$29,750 |
D/D |
25,000 |
382,015 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Business Officer and CFO |
• – – |
2023-05-18 |
4 |
B |
$1.14 |
$59,150 |
D/D |
51,700 |
357,015 |
2.74 |
% |
|
| CMRX |
Chimerix Inc |
Chief Business Officer and CFO |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
32,175 |
294,899 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Business Officer and CFO |
• – – |
2022-08-25 |
4 |
OE |
$2.09 |
$104,500 |
D/D |
50,000 |
262,724 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Business Officer and CFO |
• – – |
2022-05-17 |
4 |
B |
$1.71 |
$25,635 |
D/D |
15,000 |
212,724 |
2.74 |
% |
|
| CMRX |
Chimerix Inc |
Chief Business Officer |
• – – |
2020-03-16 |
4 |
B |
$1.43 |
$47,522 |
D/D |
33,300 |
149,729 |
2.74 |
% |
|
| CMRX |
Chimerix Inc |
Chief Business Officer |
• – – |
2019-11-06 |
4 |
B |
$1.56 |
$156,000 |
D/D |
100,000 |
100,000 |
2.74 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-12-21 |
4 |
D |
$24.00 |
$3,661,968 |
D/D |
(152,582) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500 |
152,582 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-12-17 |
4 |
OE |
$2.22 |
$55,500 |
D/D |
25,000 |
157,082 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-10-09 |
4 |
AS |
$15.85 |
$10,065 |
D/D |
(635) |
132,082 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-10-05 |
4 |
AS |
$15.55 |
$268,783 |
D/D |
(17,283) |
132,717 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
150,000 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
125,000 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2017-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
